HIV antiretroviral therapy lipid metabolism
Showing 26 - 50 of >10,000
Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)
Not yet recruiting
- Hiv
- plasma inflammatory markers
- CD4/CD8 ratio
-
Nice, FranceCHU Nice
Jan 16, 2023
Post Analytic Treatment Interruption Study
Recruiting
- HIV
-
Bangkok, ThailandSEARCH
Oct 19, 2022
HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1
Not yet recruiting
- HIV Vaccine
- Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
- +2 more
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023
HIV Trial in Cincinnati (Truvada (tenofovir/emtricitabine), Kaletra (lopinavir/ritonavir))
Completed
- HIV Infections
- Truvada (tenofovir/emtricitabine)
- Kaletra (lopinavir/ritonavir)
-
Cincinnati, OhioUniversity of Cincinnati AIDS Clinical Trials Unit
Jul 14, 2022
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)
Recruiting
- HIV-1-infection
-
Kisumu, Kenya
- +6 more
Feb 1, 2023
HIV I Infection Trial in Melbourne (Nivolumab 10 MG/ML [Opdivo], Saline)
Not yet recruiting
- HIV I Infection
- Nivolumab 10 MG/ML [Opdivo]
- Saline
-
Melbourne, Victoria, AustraliaAlfred Hospital - Department of Infecious Diseases
May 16, 2022
HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)
Not yet recruiting
- HIV-1-infection
- VRC07-523LS
- +7 more
-
Pathum Wan, Bangkok, Thailand
- +1 more
Mar 8, 2023
HIV-infected Patients Switching to Long Acting Dual Therapy
Not yet recruiting
- HIV-1-infection
- (no location specified)
Jun 24, 2022
HIV-1 Trial in Bethesda, New York (3BNC117-LS, 10-1074-LS, Sterile Saline)
Recruiting
- HIV-1
- 3BNC117-LS
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 31, 2023
HIV-1-infection Trial (TASSO device)
Not yet recruiting
- HIV-1-infection
- TASSO device
- (no location specified)
Jun 9, 2022
HIV Trial (Lipovirtide for injection)
Not yet recruiting
- HIV Infections
- Lipovirtide for injection
- (no location specified)
Apr 22, 2022
HIV Trial in El Dorado Hills (HiDO medication adherence platform, Automated Medication Platform with Video Observation, Time on
Enrolling by invitation
- HIV Infections
- HiDO medication adherence platform
- +2 more
-
El Dorado Hills, CaliforniaHiDO Technologies Inc.
Jul 7, 2022
HIV/AIDS Trial in Durham, Cape Town (iEngage (tentative title))
Not yet recruiting
- HIV/AIDS
- iEngage (tentative title)
-
Durham, North Carolina
- +1 more
Jan 3, 2023
Drug-Drug Interaction, HIV Infection Trial in Masafu, Kampala (Dihydroartemisinin-piperaquine)
Completed
- Drug-Drug Interaction
- HIV Infection
-
Masafu, Busia, Uganda
- +1 more
May 18, 2022
HIV/AIDS, Adherence, Medication, Adherence, Patient Trial in Kahama, Shinyanga (Active Arm 1, Active Arm 2)
Completed
- HIV/AIDS
- +2 more
- Active Arm 1
- Active Arm 2
-
Kahama, Shinyanga Region, Tanzania
- +3 more
Aug 18, 2022
Digestive Microbiota in Adults Living With HIV-1
Withdrawn
- HIV
- Stool sample collection
- Blood sample collection
-
Montpellier, France
- +1 more
Feb 9, 2023
HIV-1-infection Trial in Johannesburg (Doravirine/Lamivudine/Tenofovir)
Recruiting
- HIV-1-infection
-
Johannesburg, Gauteng, South Africa
- +2 more
Jun 6, 2022
Preferences for Services inPatient's First Six Months on
Not yet recruiting
- HIV
- Survey
- Focus group
-
Johannesburg, Gauteng, South Africa
- +1 more
Jul 7, 2022
Preferences for Services inPatient's First Six Months on
Not yet recruiting
- HIV
- Survey
- Focus group
-
Johannesburg, Gauteng, South Africa
- +1 more
Jul 7, 2022
HIV/AIDS, ANTIRETROVIRAL TREATMENT Trial in Mexico (iART, cART)
Recruiting
- HIV/AIDS
- ANTIRETROVIRAL TREATMENT
- iART
- cART
-
Mexico, MexicoCentro de Investigacion en Enfermedades Infecciosas
Feb 15, 2022
HIV-1-infection Trial in Mbeya (ART, 10E8.4/iMab, VRC07-523LS)
Not yet recruiting
- HIV-1-infection
- ART
- +2 more
-
Mbeya, TanzaniaNational Institute for Medical Research-Mbeya Medical Resarch Ce
Jun 6, 2023
HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)
Not yet recruiting
- HIV Associated Neurocognitive Disorder
- +3 more
- SV2A PET
- TSPO PET
- (no location specified)
Oct 16, 2022